ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE

Introduction. The crosstalk between the estrogen and growth factor receptors signaling may play an important role in the resistance to endocrine therapy. The aim of the study was to examine the relationship between the protein and receptor gene expression of transforming growth factor β type I (TGF-...

Full description

Bibliographic Details
Main Authors:	N. N. Babyshkina, S. V. Vtorushin, T. A. Dronova, N. V. Krakhmal, M. V. Zavyalova, M. M. Tsyganov, S. V. Patalyak, E. M. Slonimskaya, N. V. Cherdyntseva
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2017-06-01
Series:	Сибирский онкологический журнал
Subjects:	люминальный рак молочной железы эндокринная терапия тамоксифен рецептор трансформирующего фактора роста bi типа (tgf-bri) полиморфизм генов
Online Access:	https://www.siboncoj.ru/jour/article/view/516

Similar Items

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01)

Predictive Significance of Vascular Endothelial Growth Factor receptor VEGF-2 in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2016-11-01)

Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

Evaluation of the role of rs2227983 polymorphism of EGFR gene in the development of allergic asthma
by: A. B. Аveryanov, et al.
Published: (2022-01-01)

ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01)

MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01)

LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
by: M. V. Zavjalova, et al.
Published: (2016-02-01)

Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients
by: S. V. Vtorushin, et al.
Published: (2021-01-01)

PROBLEM AND PERSPECTIVE TO IMPROVE MOLECULAR TESTING TO CHOOSE APPROPRIATE TARGET THERAPY
by: P. A. Gervas, et al.
Published: (2016-02-01)

Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer
by: E. A. Kim, et al.
Published: (2014-08-01)

PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01)

EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT)
by: O. D. Bragina, et al.
Published: (2021-10-01)

Intercellular interactions and progression of hormonal resistance of breast cancer cells
by: S. E. Semina, et al.
Published: (2015-06-01)

The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
by: D. A. Karseladze, et al.
Published: (2014-08-01)

The Difficulties of Differential Diagnosis of the Bronchial Obstruction Syndrome
by: I. V. Demko, et al.
Published: (2021-08-01)

EGFR EXPRESSION IN RECTAL CANCER, RELATION TO THE FREAQUENCY OF LYMPH NODE METASTASIS
by: I. V. Stepanov, et al.
Published: (2017-06-01)

SINGLE NUCLEOTIDE POLYMORPHISMS IN BREAST TUMOR AND EXPRESSION OF ABC-TRANSPORTERS AFTER NEOADJUVANT CHEMOTHERAPY
by: M. M. Tsyganov, et al.
Published: (2016-02-01)

Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2009-09-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)

Genetic predictors of obstetric complications: intergenetic association
by: T B Tretyakova, et al.
Published: (2012-12-01)

POLYMORPHISM C634G OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR A GENE IN PATIENTS WITH DIABETIC FOOT IN THE TRANS-BAIKAL TERRITORY
by: Наталья Игоревна Троицкая, et al.
Published: (2023-08-01)

THE ROLE OF ALLELIC POLYMORPHISM OF RECEPTOR GENES OF INNATE IMMUNITY IN THE PERSISTENCE OF HUMAN PAPILLOMAVIRUS
by: O. P. Gumilevskaya, et al.
Published: (2016-12-01)

In vitro screening of effectiveness and antiproliferative effects of potential DDIT4 inhibitors for breast cancer cell lines
by: E. M. Zhidkova, et al.
Published: (2022-06-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015-07-01)

OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015-04-01)

Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
by: V P Komarova, et al.
Published: (2007-09-01)

Polymorphism of chemokine receptor gene CCR5 in multiple sclerosis patients and in healthy subjects in the Siberian region
by: Yu. Yu. Orlova, et al.
Published: (2006-09-01)

ANALYSIS OF ASSOCIATIONS OF VEGF-A GENE POLYMORPHISM AT POSITIONS 2578A/C AND +936C/T WITH DIFFERENT RECEPTOR STATUS IN BREAST CANCER PATIENTS
by: A. V. Shevchenko, et al.
Published: (2016-02-01)

The endometrium in women receiving adjuvant tamoxifen therapy after surgical treatment of breast cance
by: E V Dmitrieva, et al.
Published: (2013-12-01)

The mechanisms of acquired resistance to anti-EGFR drugs in non-small cell lung cancer not associated with T790m mutation and their significance in clinical practice
by: E. V. Karabina, et al.
Published: (2018-11-01)

EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
by: N. V. Litviakov, et al.
Published: (2017-12-01)

Immunological and molecular genetic characteristics of luminal B breast cancer: a literature review
by: D. A. Ryabchikov, et al.
Published: (2017-02-01)

Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
by: Il'ya Valer'evich Timofeev
Published: (2013-09-01)

Analysis of association of polymorphic variants of genes GSTP1 and GSTM1 with survival rate sick of liver cirrhosis of a virus and alcoholic etiology
by: M. I. Rachkovskiy, et al.
Published: (2009-04-01)

CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES
by: О. Е. Andreeva, et al.
Published: (2019-11-01)

Results of a preliminary analysis of the pattern of hereditary breast cancer in the women of a Kyrgyz population
by: K. B. Makieva, et al.
Published: (2014-07-01)

Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014-07-01)

Polymorphism of genes that characterize the functional state of the vascular wall in newborns born to mothers with preeclampsia
by: I. G. Popova, et al.
Published: (2022-09-01)